首页 › 基金 › Eleva Capital SAS › CLS

Eleva Capital SAS 对 CLS 的持仓历史

CELESTICA INC · 科技

Eleva Capital SAS 在 Q3 2026 的 13F 申报中披露持有 CLS(CELESTICA INC)6,564 股,市值约 US$2.4M,约占其申报组合的 2.10%,在其申报持仓中市值排名第 11 位。 Eleva Capital SAS 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)6.56K 股
申报持仓市值$2.37M
组合权重2.10%
首次申报Q3 2026
最近变动新进
更新于2026-10-09

最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR

Eleva Capital SAS 对 CLS 的持仓演变

Eleva Capital SAS 于 Q3 2026 首次披露 CLS 持仓:6,564 股(约 US$2.4M)。

逐季持仓明细

季度股数金额变化
Q3 2026 6.56K $2.37M 新进

关于 CLS 与 13F 数据

CLS(CELESTICA INC)属于科技行业。我们追踪的基金中还有 63 只申报持有 CLS,申报仓位最大的包括:CIBC WORLD MARKET INC. (US$757.8M), 德劭基金 (US$742.0M), Connor, Clark & Lunn Investment Management Ltd. (US$674.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CLS 的基金

查看 CLS 的全部基金持有人 →

常见问题

How long has Eleva Capital SAS held CLS?

Eleva Capital SAS has disclosed CLS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Eleva Capital SAS's current position in CLS?

As of Q3 2026, Eleva Capital SAS holds 6.56K shares of CLS (CELESTICA INC), valued at $2.37M, representing 2.10% of its reported portfolio and ranking #11.

Has Eleva Capital SAS been buying or selling CLS?

In the latest 13F filing (Q3 2026), Eleva Capital SAS newly opened its position in CLS.

Which other funds hold CLS?

Other major institutional holders of CLS include CIBC WORLD MARKET INC., 德劭基金, Connor, Clark & Lunn Investment Management Ltd., among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.